Cyclopharm Ltd

Cyclopharm raises A$14 million and launches a share purchase plan to boost US expansion of its Technegas® radiopharmaceutical, driving growth and investor confidence.

Cyclopharm Ltd, a Melbourne-based company, has established itself as a key player in the radiopharmaceutical industry, providing crucial products for lung and cancer tumor imaging, despite experiencing fluctuations in its share price.